Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital. (ALL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01785914
Recruitment Status : Unknown
Verified February 2013 by Benedetto Bruno, Azienda Ospedaliera San Giovanni Battista.
Recruitment status was:  Recruiting
First Posted : February 7, 2013
Last Update Posted : February 7, 2013
Sponsor:
Information provided by (Responsible Party):
Benedetto Bruno, Azienda Ospedaliera San Giovanni Battista

Brief Summary:
This study provides for the collection of a series composed by patients with newly diagnosed of acute lymphoblastic leukemia in the period 1999-2011. This collection is carried out with retrospective investigation, through the review of paper and electronic records and data cards in large part already collected as part of study protocols "GIMEMA" or "BFM" or "NILG" approved by the Ethics Committee of Hospital. The purpose of data collection is to check with retrospective predictability of classical risk factors in relation to disease response, and overall survival of the event-free survival, to estimate the cumulative incidence of competitive events such as the emergence of disease, acute and chronic transplant, the transplant-related mortality and relapse of disease.

Condition or disease
Disease: Acute Lymphoblastic Leukemia

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.
Study Start Date : February 2013
Estimated Primary Completion Date : February 2014
Estimated Study Completion Date : February 2014


Group/Cohort
1



Primary Outcome Measures :
  1. Overall survival [ Time Frame: 1 year ]
  2. Event-free survival [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Acute lymphoblastic leukemia patients
Criteria
Patients with newly diagnosed of acute lymphoblastic leukemia enrolled from 1999 to 2011 at the Division of Hematology, Molinette University Hospital and candidates for therapeutic approach with curative intent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01785914


Contacts
Layout table for location contacts
Contact: Benedetto Bruno, MD +390116336728 benedetto.bruno@unito.it
Contact: Benedetto Bruno, MD +390116336728 gismm2001@yahoo.com

Locations
Layout table for location information
Italy
Città della Salute e della Scienza di Torino Recruiting
Torino, Italy, 10126
Contact: Benedetto Bruno, MD    +390116336728    benedetto.bruno@unito.it   
Sponsors and Collaborators
Azienda Ospedaliera San Giovanni Battista
Investigators
Layout table for investigator information
Principal Investigator: Benedetto Bruno, MD Divisione di Ematologia-Città della Salute e della Scienza di Torino

Layout table for additonal information
Responsible Party: Benedetto Bruno, MD, Azienda Ospedaliera San Giovanni Battista
ClinicalTrials.gov Identifier: NCT01785914     History of Changes
Other Study ID Numbers: ALL-TO-2012
First Posted: February 7, 2013    Key Record Dates
Last Update Posted: February 7, 2013
Last Verified: February 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Lymphoid
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases